CAS 106261-49-8

Spain

2-(5-Amino-2-Methylanilino)-4-(3-Pyridyl) Pyrimidine

CAS Number

152460-10-1

End Use API

Suanfarma founded in 1993, is a B2B life science partner committed to health & innovation by developing, ...

Suanfarma founded in 1993, is a B2B life science partner committed to health & innovation by developing, manufacturing, & distributing high-quality APIs for the pharmaceutical industry innovatively & sustainably. Backed by a robust global network of 12 strategically located local offices, we cater to the needs of over 400 active customers in 70+ countries. At Suanfarma we offer our CDMO capacity for fermentation & chemical synthesis projects, offering a One Stop Shop service with a solid track record, & which allows us to achieve success in the development, scaling, manufacturing, & commercialization of an API, either innovative or generic.

CPhI North America

Booth #1352

SuanFarma is present in all origins: Natural, Chemical & Biotechnological.

Suanfarma

Spain

4-[(4-Methyl-1-Piperazinyl) Methyl] Benzoic Acid Hcl

CAS Number

106261-64-7

End Use API

Imatinib Mesylate

About the Company

Suanfarma founded in 1993, is a B2B life science partner committed to health & innovation by developing, ...

Suanfarma founded in 1993, is a B2B life science partner committed to health & innovation by developing, manufacturing, & distributing high-quality APIs for the pharmaceutical industry innovatively & sustainably. Backed by a robust global network of 12 strategically located local offices, we cater to the needs of over 400 active customers in 70+ countries. At Suanfarma we offer our CDMO capacity for fermentation & chemical synthesis projects, offering a One Stop Shop service with a solid track record, & which allows us to achieve success in the development, scaling, manufacturing, & commercialization of an API, either innovative or generic.

CPhI North America

Booth #1352

Malladi is a leader in Ephedrine, Pseudoephedrine Salts & Phenylephrine HCl // USFDA, EDQM, ANSM, KFDA, and TGA inspected.

Malladi Drugs & Pharmaceuticals Lim...

India

1-(2-Methyl-5-nitrophenyl)guanidine

Aptra Synthesis produces APIs, Pellets (Semi-finished Formulations), and Intermediates.

CAS Number

152460-07-06

End Use API

Imatinib Mesylate

About the Company

Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few ...

Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few years, Malladi established itself as a leader in manufacturing ephedrine and pseudoephedrine salts. Today, it is the leading manufacturer of APIs in the cough and cold segment. It also has a dominant presence in several therapeutic segments like antihistamines, anti-convulsants, anti-depressants and anxiolytics (CNS). Malladi exports its products to around 60 countries and over 85% of its revenue is generated from exports. Its manufacturing facilities have been approved by the FDA, EDQM, KFDA, TGA and various other regulatory agencies.

EMWA 2024

Not Confirmed

Contact Supplier

Aptra Synthesis

India

Digital Content

3-AcetyI Pyridine

Ocimum is committed to excellence in API development, manufacturing & quality.

CAS Number

350-03-8

End Use API

Imatinib Mesylate

About the Company

Aptra Synthesis Private Limited, is a reliable and vertically integrated manufacturer of APIs and interme...

Aptra Synthesis Private Limited, is a reliable and vertically integrated manufacturer of APIs and intermediates, boasting state-of-the-art manufacturing facilities that adhere to GMP standards. We take great pride in producing top-notch intermediates through our fully backward-integrated process. Aptra Synthesis Private Limited (ASPL) stands as one of the rapidly emerging manufacturers of Active Pharmaceutical Ingredients (APIs), Pellets (Semi-finished Formulations), and Intermediates.

EMWA 2024

Not Confirmed

Contact Supplier

Ocimum Labs

India

Digital Content

3-Acetylpyridine

Ocimum is committed to excellence in API development, manufacturing & quality.

URL Supplier Web Content

CAS Number

350-03-8

End Use API

Imatinib Mesylate

About the Company

Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderaba...

Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.

ASK
US

Upload
your Marketing & Sales content

Ocimum Labs

India

Digital Content

4-Methyl-3-[4-(3-pyridyl)pyrimidin-2-ylamino]aniline

Ocimum is committed to excellence in API development, manufacturing & quality.

URL Supplier Web Content

CAS Number

152460-10-1

End Use API

Imatinib Mesylate

About the Company

Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderaba...

Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.

ASK
US

Upload
your Marketing & Sales content

Ocimum Labs

India

Digital Content

1-(3-Pyridyl)-3-(dimethylamino)-2-propen-1-one

Tagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.

URL Supplier Web Content

CAS Number

55314-16-4

End Use API

Imatinib Mesylate

About the Company

Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderaba...

Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.

ASK
US

Upload
your Marketing & Sales content

Tagoor Laboratories

India

4-[(4-Methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-py...

CAS Number

152459-95-5

End Use API

Imatinib Mesylate

About the Company

Tagoor Laboratories, established in 2018, is a part of the Tagoor Group. It specializes in providing APIs...

Tagoor Laboratories, established in 2018, is a part of the Tagoor Group. It specializes in providing APIs, advanced intermediates and key starting materials for critical and high-growth therapeutic areas, with an emphasis on affordability, quality and timely delivery. It also provides end-to-end CDMO services. Headquartered in Hyderabad, Tagoor Labs is a fast-growing Indian pharma company that serves both branded and generic companies worldwide. The company’s organizational function includes R&D, supply chain, manufacturing, quality testing, quality assurance, regulatory affairs, marketing & sales, and packaging & warehousing departments.

CPhI China

Booth #E1Q18

Tagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.

Tagoor Laboratories

India

N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineam...

CAS Number

152460-10-1

End Use API

Imatinib Mesylate

About the Company

Tagoor Laboratories, established in 2018, is a part of the Tagoor Group. It specializes in providing APIs...

Tagoor Laboratories, established in 2018, is a part of the Tagoor Group. It specializes in providing APIs, advanced intermediates and key starting materials for critical and high-growth therapeutic areas, with an emphasis on affordability, quality and timely delivery. It also provides end-to-end CDMO services. Headquartered in Hyderabad, Tagoor Labs is a fast-growing Indian pharma company that serves both branded and generic companies worldwide. The company’s organizational function includes R&D, supply chain, manufacturing, quality testing, quality assurance, regulatory affairs, marketing & sales, and packaging & warehousing departments.

CPhI China

Booth #E1Q18

Tagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.

Tagoor Laboratories

India

3-Acetyl pyridine

CAS Number

350-03-8

End Use API

Imatinib Mesylate

About the Company

Tagoor Laboratories, established in 2018, is a part of the Tagoor Group. It specializes in providing APIs...

Tagoor Laboratories, established in 2018, is a part of the Tagoor Group. It specializes in providing APIs, advanced intermediates and key starting materials for critical and high-growth therapeutic areas, with an emphasis on affordability, quality and timely delivery. It also provides end-to-end CDMO services. Headquartered in Hyderabad, Tagoor Labs is a fast-growing Indian pharma company that serves both branded and generic companies worldwide. The company’s organizational function includes R&D, supply chain, manufacturing, quality testing, quality assurance, regulatory affairs, marketing & sales, and packaging & warehousing departments.

CPhI China

Booth #E1Q18